Momentum Bonitas Deal Lifts Market Share To 30%
Learn about the Momentum Bonitas Deal and its impact on South Africa's medical scheme market, raising Momentum's share to 30%.
Learn about the Momentum Bonitas Deal and its impact on South Africa's medical scheme market, raising Momentum's share to 30%.
Learn how the Parmed membership discussion evolves, with calls from MPs to allow more flexibility in medical scheme choices.
Delve into the UP study, revealing how Medical Aid Forensic Audits are destabilising private practices and affecting practitioners.
Learn how the advent of Generic Semaglutide in India will change the landscape of weight-loss and diabetes medications.
Learn how Animal Testing Alternatives can accelerate R&D and improve human relevance in safety data and drug development.
AI Health Prompts at Discovery Life are nudging members to get screened, helping catch cancer earlier and supporting healthier lives.